Search research articles

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age, Multidomain Lifestyle Intervention, and White Matter Integrity: Secondary Analysis of the POINTER Randomized Clinical Trial.

JAMA network open·2026

Same author

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026

Same author

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

bioRxiv : the preprint server for biology·2026

Same author

Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers.

JAMA neurology·2026

Same author

Features predicting data exclusion in imaging studies of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Same author

Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery.

Brain : a journal of neurology·2026

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Sep 27, 2025

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

A robust and interpretable machine learning approach using multimodal biological data to predict future pathological

Joseph Giorgio¹, William J Jagust^2,3, Suzanne Baker³

¹Department of Psychology, University of Cambridge, Cambridge, UK.

Nature Communications

|April 8, 2022

Summary

This study introduces a machine learning tool to predict Alzheimer's disease (AD) progression by analyzing key biomarkers. The approach stratifies patients and forecasts tau accumulation, aiding early intervention and clinical trials.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Sep 27, 2025

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

Neuroscience
Biomedical Engineering

Background:

Early Alzheimer's disease (AD) involves complex pathophysiological interactions.
Current tools lack robustness in predicting individual disease progression trajectories.

Purpose of the Study:

To develop a machine learning approach for predicting future pathological tau accumulation in early AD.
To quantify interactions between key AD pathological markers (amyloid, atrophy, tau, APOE4) in preclinical and mild stages.

Main Methods:

Utilized a robust and interpretable machine learning model.
Combined multimodal biological data, including baseline non-tau markers.
Derived a prognostic index for stratifying patients and predicting tau accumulation.

Main Results:

The prognostic index effectively stratifies patients based on future tau accumulation.
Accurate prediction of individualized regional tau accumulation rates was achieved.
The model successfully translated predictions from patient cohorts to cognitively normal individuals.

Conclusions:

The developed machine learning approach offers robust, fine-scale stratification and prognostication for early AD.
This method has significant implications for designing clinical trials targeting the earliest stages of Alzheimer's disease.